X-linked agammaglobulinaemia (Q102707): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed an Item |
||||||||||||||
| (6 intermediate revisions by the same user not shown) | |||||||||||||||
| description / pt-br | description / pt-br | ||||||||||||||
Agamaglobulinemia ligada ao X é uma doença hereditária recessiva ligada ao X marcada por infecções bacterianas recorrentes nas vias aéreas e no trato GI. Também predispõe os indivíduos afetados a infecções crônicas por enterovírus. Ocorre com uma prevalência de aproximadamente 1:200.000. A doença é causada pela produção deficiente de imunoglobulina como resultado de mutações no gene que codifica a tirosina quinase de Bruton (Btk) e é caracterizada por comprometimento da maturação dos linfócitos B. Os pacientes são tratados com injeções endovenosas ou subcutâneas regulares de imunoglobulina. | |||||||||||||||
| description / en | description / en | ||||||||||||||
X-linked agammaglobulinemia is an X-linked recessive inherited disease marked by recurrent bacterial infections in the airways and GI tract. It also predisposes affected individuals to chronic enterovirus infections. It occurs with a prevalence of approximately 1:200,000. The disease is caused by the deficient production of immunoglobulin as a result of mutations in the gene coding for Bruton's tyrosine kinase (Btk) and is characterised by impaired maturation of B lymphocytes. Patients are treated with regular venous or subcutaneous injections of immunoglobulin. | |||||||||||||||
| Property / Canonical URI | |||||||||||||||
| Property / Canonical URI: https://id.who.int/icd/entity/1594688835 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / CURIE | |||||||||||||||
CID11:ID_1594688835 | |||||||||||||||
| Property / CURIE: CID11:ID_1594688835 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Canary Token | |||||||||||||||
dki-india-ID_1594688835 | |||||||||||||||
| Property / Canary Token: dki-india-ID_1594688835 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Verification Status | |||||||||||||||
Concluído | |||||||||||||||
| Property / Verification Status: Concluído / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
15 August 2026
| |||||||||||||||
| Property / Collection date: 15 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 19:54, 16 August 2026
X-linked agammaglobulinemia is an X-linked recessive inherited disease marked by recurrent bacterial infections in the airways and GI tract. It also predisposes affected individuals to chronic enterovirus infections. It occurs with a prevalence of approximately 1:200,000. The disease is caused by the deficient production of immunoglobulin as a result of mutations in the gene coding for Bruton's tyrosine kinase (Btk) and is characterised by impaired maturation of B lymphocytes. Patients are treated with regular venous or subcutaneous injections of immunoglobulin.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_1594688835 |
||
| English | X-linked agammaglobulinaemia |
X-linked agammaglobulinemia is an X-linked recessive inherited disease marked by recurrent bacterial infections in the airways and GI tract. It also predisposes affected individuals to chronic enterovirus infections. It occurs with a prevalence of approximately 1:200,000. The disease is caused by the deficient production of immunoglobulin as a result of mutations in the gene coding for Bruton's tyrosine kinase (Btk) and is characterised by impaired maturation of B lymphocytes. Patients are treated with regular venous or subcutaneous injections of immunoglobulin. |
Statements
CID11:ID_1594688835
0 references
dki-india-ID_1594688835
0 references
Concluído
0 references
15 August 2026
0 references
